Holen Sie sich die Stockscreener-App
0.83
0.42%
-0.0035
Handel nachbörslich:
.83
Schlusskurs vom Vortag:
$0.8335
Offen:
$0.833
24-Stunden-Volumen:
105.41K
Relative Volume:
0.79
Marktkapitalisierung:
$16.23M
Einnahmen:
$411.00K
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-1.8864
EPS:
-0.44
Netto-Cashflow:
$-4.88M
1W Leistung:
-1.07%
1M Leistung:
-5.78%
6M Leistung:
-45.75%
1J Leistung:
-74.30%
1-Tages-Spanne:
$0.8111
$0.85
1-Wochen-Bereich:
$0.7777
$0.8625
52-Wochen-Spanne:
$0.7777
$4.38
Lexaria Bioscience Corp Stock (LEXX) Company Profile
Firmenname
Lexaria Bioscience Corp
Sektor
Branche
Telefon
250-765-6424
Adresse
100 - 740 MCCURDY ROAD, KELOWNA
Vergleichen Sie LEXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LEXX
Lexaria Bioscience Corp
|
0.83 | 16.30M | 411.00K | -4.85M | -4.88M | -0.44 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Lexaria Bioscience Corp Aktie (LEXX) Neueste Nachrichten
Chart based analysis of Lexaria Bioscience Corp. Equity Warrant trendsWeekly Trend Summary & Real-Time Buy Zone Alerts - Newser
What Fibonacci levels say about Lexaria Bioscience Corp. rebound2025 Performance Recap & Real-Time Chart Breakout Alerts - Newser
Will a bounce in Lexaria Bioscience Corp. offer an exitGap Down & Entry and Exit Point Strategies - Newser
Pattern recognition hints at Lexaria Bioscience Corp. upsideAnalyst Upgrade & Daily Stock Trend Reports - Newser
Lexaria Bioscience Corp. Equity Warrant recovery potential after sell offJuly 2025 Summary & Precise Trade Entry Recommendations - Newser
Leading vs lagging indicators on Lexaria Bioscience Corp. Equity Warrant performanceLayoff News & Smart Investment Allocation Insights - Newser
Why Lexaria Bioscience Corp. Equity Warrant stock attracts strong analyst attention2025 Trade Ideas & Verified Short-Term Plans - Newser
Why Lexaria Bioscience Corp. stock attracts strong analyst attentionEarnings Trend Report & Long Hold Capital Preservation Plans - Newser
What MACD and RSI say about Lexaria Bioscience Corp. Equity WarrantMomentum Prediction Based on AI Backtesting - Newser
Will Lexaria Bioscience Corp. Equity Warrant stock go up soonPortfolio Update Summary & Community Consensus Trade Alerts - Newser
Detecting support and resistance levels for Lexaria Bioscience Corp. Equity Warrant [2025 Year in Review]Safe Capital Growth Stock Tips - Newser
Should I hold or sell Lexaria Bioscience Corp. Equity Warrant nowFree Portfolio Health Check - newsyoung.net
Lexaria Bioscience Corp. Equity Warrant stock chart pattern explainedStrategy Playbook for Risk Controlled Trades - Newser
Will Lexaria Bioscience Corp. Equity Warrant bounce back from current supportEarly Buy Opportunity with Chart Triggers - Newser
How to read the order book for Lexaria Bioscience Corp.Deep Learning Stock Forecast for Investors - Newser
What is Lexaria Bioscience Corp. s revenue forecastROI Enhanced Trading Plan - newsyoung.net
Is Lexaria Bioscience Corp. Equity Warrant Stock a Smart Buy in 2025 Investment Analysis Inside - Newser
Risk adjusted return profile for Lexaria Bioscience Corp. analyzedPredictive System for Long-Term Stock Forecast - Newser
Is Lexaria Bioscience Corp. Equity Warrant trending in predictive chart modelsFree Weekly Chart Analysis With Entry Advice - Newser
Will earnings trigger a reversal in Lexaria Bioscience Corp. Equity WarrantFree Growth Based Stock Signal Screener - Newser
Exit strategy if you’re trapped in Lexaria Bioscience Corp.Machine Learning Intraday Signal Forecast - Newser
What makes Lexaria Bioscience Corp. Equity Warrant stock price move sharplyAlgorithmic Forecast for Swing Trading Picks - Newser
Risk vs reward if holding onto Lexaria Bioscience Corp.Sector-Wise Stock Strength Trend Analysis - Newser
What to expect from Lexaria Bioscience Corp. Equity Warrant in the next 30 daysPredictable Return Strategy with AI Support - Newser
Is Lexaria Bioscience Corp. Equity Warrant showing signs of accumulationFree Low Risk Picks for Daily Trading - Newser
Does Lexaria Bioscience Corp. show high probability of reboundBear Market Safe Zone Technical Analysis - Newser
What technical models suggest about Lexaria Bioscience Corp. Equity Warrant’s comebackStock Price Prediction Using AI Tools - Newser
What makes Lexaria Bioscience Corp. stock price move sharplyTechnical Setup and Return Forecast Engine - Newser
How Lexaria Bioscience Corp. Equity Warrant stock performs during market volatilityWatchlist Summary for Active Day Traders - Newser
Lexaria Bioscience Corp. stock outlook for YEARRisk/Reward Optimization Entry Point Analysis - Newser
Will Lexaria Bioscience Corp. continue its uptrendProfit Target Planning with Exit Confidence - Newser
Using fundamentals and technicals on Lexaria Bioscience Corp. Equity WarrantSwing Candidate List with Trade Cues - Newser
How Interest Rate Changes Impact Lexaria Bioscience Corp. Stock PerformanceFree Stock Selection With High Accuracy - Newser
Chartists See Breakout Potential in Lexaria Bioscience Corp.Earnings Play Trade Plan With Alerts Shared - beatles.ru
Lexaria's Newest DehydraTECH(TM) 2.0 Formulation Tested In Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption Results Ever - Barchart.com
What MACD and RSI say about Lexaria Bioscience Corp.Free Breakout Confirmation With Entry Tracker - Newser
Transactions sur Actions Propres de Compagnie Lebon en Juillet 2025 - AInvest
Lexaria Bioscience Corp: A Pioneer in GLP-1 Drug Delivery with DehydraTECH Technology - AInvest
Lexaria Bioscience Targets GLP-1 Market with DehydraTECH Innovation - TipRanks
GLP-1 "Arms Race" Broadens to Include Dozens of Companies | LEXX Stock News - GuruFocus
GLP-1 "Arms Race" Broadens to Include Dozens of Companies - TradingView
Revolutionary Technology Eliminates GLP-1 Side Effects: Lexaria's Solution for Ozempic, Wegovy Users - Stock Titan
Forecasting Lexaria Bioscience Corp. price range with options dataFree Smart Trend Trading with Weekly Signals - Newser
Lexaria Strengthens Its International Patent Portfolio To 19 Patents Granted - Barchart.com
When is Lexaria Bioscience Corp. Equity Warrant stock expected to show significant growthBuild wealth steadily with expert advice - Jammu Links News
How volatile is Lexaria Bioscience Corp. stock compared to the marketDiscover hidden gems in the stock market - Jammu Links News
What is Lexaria Bioscience Corp. company’s growth strategyGet alerts on the hottest market movers - Jammu Links News
Should I hold or sell Lexaria Bioscience Corp. stock in 2025Market-leading capital gains - Jammu Links News
How strong is Lexaria Bioscience Corp. Equity Warrant company’s balance sheetBuild wealth steadily with proven stock picks - Jammu Links News
What are analysts’ price targets for Lexaria Bioscience Corp. in the next 12 monthsOutstanding growth strategies - Jammu Links News
What are the technical indicators suggesting about Lexaria Bioscience Corp.Discover the fastest growing stocks today - Jammu Links News
Finanzdaten der Lexaria Bioscience Corp-Aktie (LEXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):